Announcement on Obtaining the U.S. FDA Approval for the Product Gabapentin Capsules

About this update from Zhejiang Huahai Pharmaceutical Co., Ltd. Class A

Announcement on Obtaining the U.S. FDA Approval for the Product Gabapentin Capsules The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang Huahai Pharmaceutical Co., Ltd. Class A